DJIA 17,035.61 -3.88 -0.02%
NASDAQ 4,544.61 12.51 0.28%
S&P 500 1,992.19 -0.18 -0.01%
market minute promo

Osiris Therapeutics, Inc. (NASDAQ: OSIR)



company name or ticker

Journal Publishes Grafix Clinical Study for Chronic Wounds

3 Ways 3-D Bioprinting Can Disrupt the Health-Care Industry

Will 3-D bioprinting technology from companies such as Organovo disrupt older technologies from Boston Scientific, Osiris Therapeutics, and Hanger?

MiMedx (MDXG) in Focus: Stock Moves 13.8% Higher - Tale of the Tape

Can Achillion Pharmaceuticals (ACHN) Continue to Surge? - Tale of the Tape

Osiris Therapeutics Inc. Stock Upgraded (OSIR)

Why Osiris Therapeutics Inc. Shares Tanked

Shareholders react negatively to the departure of an important piece of the Osiris Therapeutics puzzle.

CMS Payment Rules Open Key Doors For AutoloGel

Osiris Focuses On Biosurgery After Selling Prochymal, Stock Attractively Valued

5 Stocks Poised for Breakouts

Osiris Therapeutics Reports CMS Decides to Package Reimbursement for Products Used in Advanced Wound

Osiris Therapeutics Reports CMS Decides to Package Reimbursement for Products Used in Advanced Wound Care with the Related Surgical Procedure into Two-Tier System
See More Articles...